medigraphic.com
SPANISH

MEDICC Review

ISSN 1527-3172 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 2-3

<< Back Next >>

MEDICC Review 2019; 21 (2-3)

Biochemical markers and hypertension in children

Garí-Llanes M, García-Nóbrega Y, Chávez-González E, González-Rodríguez E, García-Sáez J, Llanes-Camacho MC
Full text How to cite this article

Language: English
References: 52
Page: 10-15
PDF size: 149.05 Kb.


Key words:

adolescent, child, hypertension, apolipoproteins, cardiovascular diseases, risk factors, Cuba.

ABSTRACT

INTRODUCTION Hypertension is one of the most studied risk factors for cardiovascular disease in adults; in children and adolescents, its global prevalence changes with age, from 1%–3% in children to 3.2% in adolescents. In adults, in addition to hypertension, several biochemical markers of cardiovascular risk have been identified. Confirming an association between these and hypertension in childhood and adolescence would allow for more timely diagnosis and monitoring of cardiovascular disease, since the presence of both the markers and hypertension would imply increased risk.
OBJECTIVE Confirm an association between biochemical risk markers of cardiovascular disease and hypertension in children aged 8 to 11 years.
METHODS A cross-sectional study of 373 children aged 8–11 years was conducted in 3 primary schools in the city of Santa Clara in central Cuba. The variables examined were age, sex, height, blood pressure, cholesterol, triglycerides, lipoproteins and apolipoproteins. The children were classified as normotensive, prehypertensive or hypertensive, based on blood pressure readings and percentiles for age, sex and height. Descriptive statistics were calculated for quantitative variables. A bivariate analysis, tests of independence for qualitative variables and a means comparison for quantitative variables (ANOVA and its nonparametric alternative, the Kruskal Wallis test) were performed. Fisher’s F-test and its associated probability value were employed.
RESULTS Some 32.2% of the children were prehypertensive and 5.1% hypertensive. Cholesterol and triglyceride values were significantly higher in hypertensive than in normotensive children (p = 0.028 and p = 0.047, respectively). HDL numbers were higher in normotensive children (p =0.001), and LDL numbers and the LDL/HDL ratio were higher in the hypertensive children, with differences between groups (p = 0.001 for both variables). There were differences between the three blood pressure categories for lipoprotein(a) and ApoA (p <0.001 and p = 0.001), for ApoB and for the ApoB/ApoA ratio (p <0.001 for both variables), with lower ApoA values and higher ApoB and ApoB/ApoA values in the hypertensive children.
CONCLUSIONS The biochemical risk markers most strongly associated with hypertension in children are ApoB values, LDL, lipoprotein(a), and LDL/HDL and ApoB/ApoA ratios.


REFERENCES

  1. Benjamin EJ, Virani SS, Callaway CW, Chang AR, Cheng S, Chiuve SE, et al. Heart disease and stroke statistics–2018 update: a report from the American Heart Association [published online ahead of print January 31, 2018]. Circulation [Internet]. 2019 Mar 5 [cited Apr 10];139(10) e56–528. Available from: http://www.ahajournals. org/doi/full/10.1161/CIR.0000000000000659?url _ver=Z39.88-2003&rfr_id=ori:rid:crossref .org&rfr_dat=cr_pub%3dpubmed

  2. National Health Statistics and Medical Records Division (CU). Anuario Estadístico de Salud 2017 [Internet]. Havana: Ministry of Public Health (CU); 2018 [cited 2019 Jan 12]. 206 p. Available from: http://bvscuba.sld.cu/anuario-estadistico-de -cuba/. Spanish.

  3. Rodríguez Domínguez L, Díaz Sánchez ME, Ruiz Álvarez V, Hernández Hernández H, Herrera Gómez V, Montero Díaz M. Factores de riesgo cardiovascular y su relación con la hipertensión arterial en adolescentes. Rev Cubana Med [Internet]. 2014 [cited 2019 Jan 12];53(1):25–36. Available from: http://scielo.sld.cu/pdf/med/v53n1/ med04114.pdf. Spanish.

  4. Llapur Milián R, González Sánchez R. Comportamiento de los factores de riesgo cardiovascular en niños y adolescentes con hipertensión arterial esencial. Rev Cubana Pediatr [Internet]. 2006 Jan–Mar [cited 2019 Jan 12];78(1). Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&p id=S0034-75312006000100007. Spanish.

  5. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health [Internet]. 2005 [cited 2019 Jan 12];95 Suppl 1:S144–50. Available from: https://ajph.aphapubli cations.org/doi/pdf/10.2105/AJPH.2004.059204

  6. Núñez Robles E, Huapaya Pizarro C, Torres Lao R, Esquivel León S, Suárez Moreno EV, Yasuda Espinoza M, et al. Prevalencia de factores de riesgo cardiovascular y riesgo metabólico en escolares, universitarios y mujeres de organizaciones sociales de base en distritos de Lima, Callao, La Libertad y Arequipa, Perú 2011. Rev Perú Med Exp Salud Pública [Internet]. 2014 Oct–Dec [cited 2019 Jan 12];31(4):652–9. Available from: http:// www.scielo.org.pe/scielo.php?script=sci_arttext &pid=S1726-46342014000400006. Spanish.

  7. Abraham CW, Blanco GH, Coloma G, Cristaldi A, Gutiérrez N, Sureda L. ERICA Estudio de los factores de riesgo cardiovascular en adolescentes. Rev Fed Arg Cardiol [Internet]. 2013 Jan–Mar [cited 2019 Jan 12];42(1):29–34. Available from: http://www.imbiomed.com.mx /1/1/articulos.php?method=showDetail&id _articulo=91549&id_seccion=4470&id _ejemplar=8978&id_revista=289. Spanish.

  8. Sáez Y, Bernui I. Prevalencia de factores de riesgo cardiovascular en adolescentes de instituciones educativas. An Fac Med [Internet]. 2009 Dec [cited 2019 Feb 20];70(4):259–65. Available from: http://www.scielo.org.pe/scielo.php?script=sci_art text&pid=S1025-55832009000400006. Spanish.

  9. Briceño G, Céspedes J, Leal M, Vargas S. Prevalencia de factores de riesgo cardiovascular en escolares de un área rural y urbana de Colombia. Biomédica [Internet]. 2018 Dec 1 [cited 2019 Feb 20];38(4):545–54. Available from: https:// www.revistabiomedica.org/index.php/biomedica/ article/view/4223. Spanish.

  10. Medrano Donlucas G, Acosta Favela JA, Ruiz Morales ME, Vargas Esquivel JA. Principales factores de riesgo cardiovascular en escolares. Culcyt [Internet]. 2014 Sep–Dec [cited 2019 Feb 20];11(54):72–80. Available from: http://erevis tas.uacj.mx/ojs/index.php/culcyt/article/view File/869/821. Spanish.

  11. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescent. The Fourth Report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics [Internet]. 2004 [cited 2019 Jan 12];114(2 Suppl):555–76. Available from: http:// pediatrics.aappublications.org/content/114/Supplement_ 2/555.long

  12. National Health Statistics and Medical Records Division (CU). Anuario Estadístico de Salud 2017 [Internet]. Havana: Ministry of Public Health (CU); c2018 [cited 2019 Jan 12]. Table 76, Prevalencia de diabetes mellitus, hipertensión arterial y asma bronquial según grupo de edad y sexo; p. 97. Available from: http://fi les .sld.cu/dne/files/2018/04/Anuario-Electronico -Espa%C3%B1ol-2017-ed-2018.pdf. Spanish.

  13. Zócalo Y, Arana M, García V, Mattos V, Curcio S, Farro I, et al. Estudios arteriales no-invasivos para detección temprana o valoración de cambios arteriales en niños y jóvenes expuestos a factores de riesgo cardiovascular y/o patologías sistémicas. Arch Pediatr Urug [Internet]. 2015 Sep [cited 2019 Feb 20];86(3):197–207. Available from: http://www.scielo.edu.uy/scielo.php?pid=S1688 -12492015000300006&script=sci_arttext. Spanish.

  14. García Sánchez N. Sobre los indicadores bioquímicos del daño arterioesclerótico. Rev Cubana Aliment Nutr [Internet]. 2017 Jan–Jun [cited 2019 Jan 12];27(1):189–210. Available from: http://www.medigraphic.com/pdfs/revcubalnut/ can-2017/can171m.pdf. Spanish.

  15. Benozzi S, Coniglio RI. Aterosclerosis: biomarcadores plasmáticos emergentes. Acta Bioquím Clín Latinoam [Internet]. 2010 Jul–Sep [cited 2019 Jan 20];44(3):317–28. Available from: http:// www.scielo.org.ar/scielo.php?script=sci_arttext& pid=S0325-29572010000300003. Spanish.

  16. Ferrer Arrocha M, Fernández-Britto Rodríguez JE, Piñeiro Lamas R, Carballo Martínez R, Sevilla Martínez D. Obesidad e hipertensión arterial: señales ateroscleróticas tempranas en los escolares. Rev Cubana Pediatr [Internet]. 2010 Oct– Dec [cited 2019 Feb 20];82(4):20–30. Available from: http://scielo.sld.cu/scielo.php?script=sci_art text&pid=S0034-75312010000400003. Spanish.

  17. Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens [Internet]. 2009 Sep [cited 2019 Feb 20];27(9):1719–42. Available from: https://journals.lww.com/jhypertension/full text/2009/09000/Management_of_high_blood _pressure_in_children_and.1.aspx

  18. Sociedad Argentina de Pediatría Subcomisiones, Comités y Grupos de Trabajo. Consenso sobre manejo de las dislipidemias en pediatría. Arch Argent Pediatr [Internet]. 2015 [cited 2018 Feb 20];113(2):177–86. Available from: https://www .sap.org.ar/docs/publicaciones/archivo sarg/2015/v113n2a23.pdf. Spanish.

  19. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens [Internet]. 2003 Jun [cited 2018 Dec 10];21(6):1011–53. Available from: www.ncbi .nlm.nih.gov/pubmed/12777938

  20. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA [Internet]. 2013 Nov 27 [cited 2018 Dec 10];310(20):2191–4. Available from: https://jamanetwork.com/journals/ jama/fullarticle/1760318

  21. van Delden JJM, van der Graaf R. Revised CIOMS International Ethical Guidelines for health-related research involving humans. JAMA [Internet]. 2016 Dec 6 [cited 2019 Feb 20]. Available from: http://redceih.bvs.hn/wp-content/ uploads/2016/12/RevisedCIOMSGuidelines _JAMA_December2016.pdf

  22. Falkner B, Gidding SS. Prehipertensión en los adolescentes. Hypertension [Internet]. 2008 Dec [cited 2019 Feb 12];25(6):245–8. Available from: https://www.sciencedirect.com/science/article/ pii/S0212824108757682. Spanish.

  23. O’Donnell CJ, Elosua R. Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study. Rev Esp Cardiol [Internet]. 2008 Mar [cited 2019 Feb 12];61(3):299–310. Available from: http://www.revespcardiol.org/ es/factores-riesgo-cardiovascular-perspectivas -derivadas/articulo/13116658/. Spanish.

  24. Salazar Vázquez B, Rodríguez Morán M, Guerrero Romero F. Factores bioquímicos asociados a riesgo cardiovascular en niños y adolescentes. Rev Med IMSS [Internet]. 2005 Jul–Aug [cited 2019 Feb 20];43(4):299–303. Available from: http://www.medigraphic.com/pdfs/imss/im-2005/ im054e.pdf

  25. Grupo Hipertensión; Deregibus M, Haag D, Ferrario C. Consenso sobre factores de riesgo de enfermedad cardiovascular en pediatría. Hipertensión arterial en niños y adolescentes. Arch Argent Pediatr [Internet]. 2005 [cited 2019 Feb 17];103(4):348–66. Available from: https://www.sap.org.ar/uploads/consensos/ consenso-sobre-factores-de-riesgo-de-enferme dad-cardiovascular-en-pediatr-iacutea-hiperten si-oacuten-arterial-en-el-ni-ntildeo-y-el-adoles cente-hipercolesterolemia.pdf. Spanish.

  26. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation [Internet]. 2007 Jan 30 [cited 2019 Feb];115(4):450–8. Available from: https://www.ahajournals.org/ doi/10.1161/CIRCULATIONAHA.106.637793

  27. Gotthelf SJ, Jubany LL. Prevalencia de factores de riesgo cardiovascular en adolescentes de escuelas públicas y privadas de la ciudad de Salta, año 2009. Arch Argent Pediatr [Internet]. 2010 Sep–Oct [cited 2019 Feb 17];108(5):418–26. Available from: http://www .scielo.org.ar/scielo.php?script=sci_arttext&pid =S0325-00752010000500007. Spanish.

  28. Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension [Internet]. 2006 Jan [cited 2019 Feb 20];47(1):45–50. Available from: https://www.ahajournals.org/doi/ full/10.1161/01.HYP.0000196306.42418.0e?url _ver=Z39.88-2003&rfr_id=ori:rid:crossref .org&rfr_dat=cr_pub%3dpubmed

  29. Royo-Bordonada MA, Garcés C, Gorgojo L, Martín- Moreno JM, Lasunción MA, Rodríguez Artalejo F, et al. Saturated fat in the diet of Spanish children: relationship with the anthropometrical, alimentary, nutritional and lipid profi les. Public Health Nutr [Internet]. 2006 Jun [cited 2019 Feb 20];9(4):429–35. Available from: https:// www.cambridge.org/core/product/identifier/ S1368980006000759/type/journal_article

  30. Escudero-Lourdes GV, Morales-Romero LV, Valverde-Ocaña C, Velasco-Chávez JF. Riesgo cardiovascular en en población infantil de 6 a 15 años con obesidad exógena. Rev Med Inst Mex Seguro Soc [Internet]. 2014 [cited 2019 Feb 20];52(Suppl 1): S58–63. Available from: http://www.medigraphic.com/pdfs/imss/im-2014/ ims141j.pdf. Spanish.

  31. Sáez Y, Bernui I. Prevalencia de factores de riesgo cardiovascular en adolescentes de instituciones educativas. An Fac Med [Internet]. 2009 [cited 2019 Jan 12];70(4):259–65. Available from: http://www.scielo.org.pe/pdf/afm/v70n4/ a06v70n4.pdf. Spanish.

  32. Romero Velarde E, Campollo Rivas O, Celis de la Rosa A, Vásquez-Garibay EM, Castro- Hernández JF, Cruz-Osorio RM. Factores de riesgo de dislipidemia en niños y adolescentes con obesidad. Salud Pública Mex [Internet]. 2007 Mar–Apr [cited 2019 Jan];49(2):103–8. Available from: https://scielosp.org/pdf/spm/2007 .v49n2/103-108/es. Spanish.

  33. Cuartas S, Pérez Torre M. Evaluación comparativa entre el colesterol no-HDL y el colesterol-LDL en niños y adolescentes. Rev Cubana Pediatr [Internet]. 2017 [cited 2019 Jan 12];89(1):20–9. Available from: http://scielo.sld.cu/pdf/ped/ v89n1/ped04117.pdf. Spanish.

  34. Leguen-Gulgar L, Castellanos M, Sánchez-Bouza MJ, Benet-Rodríguez M. Factores de riesgo cardiovasculares y su relación con las alteraciones del metabolismo de los glúcidos y lípidos. Rev Finlay [Internet]. 2014 Dec [cited 2018 Dec 17];4(4):248–60. Available from: http://www.rev finlay.sld.cu/index.php/finlay/article/view/326. Spanish.

  35. LLapur Milián R, González SR, Borges Alfonso K, Rubio Olivares DY. Alteraciones lipídicas en la hipertensión arterial esencial. Rev Cubana Pediatr [Internet]. 2013 [cited 2018 Dec];85(3):283– 94. Available from: http://bvs.sld.cu/revistas/ped/ vol85_3_13/ped02313.htm. Spanish.

  36. Galarza Carrión GE. Adolescencia e hipertensión arterial. Rev Ciencias Méd [Internet]. 2014 Sep–Oct [cited 2019 Feb];18(5):743–52. Available from: http://scielo.sld.cu/scielo.php?script=sci_artt ext&pid=S1561-31942014000500004. Spanish.

  37. Real Delor R, Duarte SE, López Encarnación N. Factores de riesgo cardiovascular en adolescentes de una ciudad del Paraguay. Acta Med Colomb [Internet]. 2017 [cited 2019 Feb 20];42(1):30–4. Available from: http://www .scielo.org.co/pdf/amc/v42n1/0120-2448 -amc-42-01-00030.pdf. Spanish.

  38. Calandrelli M, Saavedra ME, Trevisán M, Zgaib ME, Parola M, Ferrante D. Relevamiento de factores de riesgo cardiovascular en Bariloche. Rev Argent Cardiol [Internet]. 2011 Aug [cited 2019 Jan];79(4):344–50. Available from: http://www .scielo.org.ar/scielo.php?script=sci_arttext&pid =S1850-37482011000400007. Spanish.

  39. Ruiz Mori E. Riesgo y Prevención Cardiovascular [Internet]. [place unknown]: [publisher unknown]; [cited 2018 Dec 17]. 135 p. Available from en: http://www.sscardio.org/wp-content/ uploads/2016/11/RIESGO-CARDIOVASCULAR -V44-copia.pdf. Spanish.

  40. González-Requejo A, Sánchez-Bayle M, Ruiz- Jarabo C, Asensio Antón J, Peláez MJ, Morales MT, et al. Lipoprotein(a) and cardiovascular risk factors in a cohort of 6 year old children. The Rivas-Vaciamadrid study. Eur J Pediatr [Internet]. 2003 Sep [cited 2019 Jan];162(9):572–5. Available from: http://www.elsevier.es/index .php?p=revista&pRevista=pdf-simple&pii=S0214 916804789962&r=8

  41. Sáez Meabe Y, Lafi ta Bernar M, Sáez de Lafuente Chivite JP, Narváez Gofi nondo I, Vacas Rius M, Magro López AM, et al. Correlación de los perfi les lipoproteicos y variables antropométricas con concentraciones séricas de lipoproteína(a) en la infancia. An Pediatr [Internet]. 2006 Mar [cited 2019 Jan];64(3):221–326. Available from: http://www.analesdepediatria.org/es-correlacion -los-perfiles-lipoproteicos-variables-articulo -resumen-13085509. Spanish.

  42. Dalmau Serra J. Nuevos factores de riesgo cardiovascular detectables en la edad pediátrica. An Esp Pediatr [Internet]. 2001 May [cited 2019 Jan];54(3):1–72. Available from: http://www.ana lesdepediatria.org/es-nuevos-factores-riesgo -cardiovascular-detectables-articulo-13012919. Spanish.

  43. Álvarez Caro F, Díaz Martín JJ, Riaño Galán I, Pérez Solís D, Venta Obaya R, Málaga Guerrero S. Factores de riesgo cardiovascular clásico y emergente en escolares asturianos. An Pediatr [Internet]. 2011 Jun 1 [cited 2019 Feb 15];74(6):388–95. Available from: https://doi .org/10.1016/j.anpedi.2011.01.007. Spanish.

  44. Torres-Colores J, González-Bárcena D, Muñoz- Solís A. Relación apolipoproteína B/Apolipoproteína AI y componentes del síndrome metabólico en adolescentes con obesidad: Efecto de una dieta hipocalórica baja en carbohidratos. Acta Médica Grupo Ángeles [Internet]. 2006 Apr–Jun [cited 2019 Jan];4(2):81–8. Available from: http:// www.medigraphic.com/pdfs/actmed/am-2006/ am062a.pdf. Spanish.

  45. Moreira Lima L, Carvalho MG, Sousa Oliveira M. Índice apo B/apo A-I e predição de risco cardiovascular. Arq Bras Cardiol [Internet]. 2007 [cited 2019 Jan 12];88(6):140–3. Available from: http://www.scielo.br/scielo.php?script=sci _arttext&pid=S0066-782X2007000600014&lng= pt&nrm=iso&tlng=pt. Portugues, English.

  46. Sierra-Johnson J, Fisher RM, Romero Corral A, Somers VK, López Jiménez F, Öhrvik J. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: fi ndings from a multi-ethnic US population. Eur Heart J [Internet]. 2009 Mar [cited 2019 Feb 20];30(6):710–7. Available from: https://www .ncbi.nlm.nih.gov/pmc/articles/PMC2721712/

  47. Vélez C, Gil LM, Ávila CL, López A. Factores de riesgo cardiovascular y variables asociadas en personas de 20 a 79 años en Manizales, Colombia. Rev Univ Salud [Internet]. 2015 [cited 2019 Feb];17(1):32–46. Available from: http://www.scie lo.org.co/pdf/reus/v17n1/v17n1a04.pdf. Spanish.

  48. Graffi gna M, Soutelo J, Catoira N, Azpelicueta AM, Perel C, Aranguren M, et al. Alteraciones lipídicas en adolescentes de peso adecuado. Insuf Card [Internet]. 2017 Dec [cited 2019Jan15];12(4):153–9. Availablefrom: http://www .scielo.org.ar/scielo.php?script=sci_arttext&pid =S1852-38622017000400003. Spanish.

  49. Castillo Arocha I, Armas Rojas NB, Dueñas Herrera A, González Greck OR, Arocha Mariño C, Castillo Guzmán A. Riesgo cardiovascular según tablas de la OMS, el estudio Framingham y la razón apolipoproteína B/ apolipoproteína A1. Rev Cubana Invest Bioméd [Internet]. 2010 Oct–Dec [cited 2019 Jan];29(4):479–88. Available from: http://scielo .sld.cu/scielo.php?script=sci_arttext&pid=S0864 -03002010000400008&lng=es. Spanish.

  50. Moreira Lima L, Carvalho MG, Sousa Oliveira M. Índice apo B/apo A-I e predição de risco cardiovascular. Arq Bras Cardiol [Internet]. 2007 [cited 2019 Jan];88(6):e187–e90. Available from: http://dx.doi.org/10.1590/S0066- 782X2007000600014. Portugues, English.

  51. Fernández V, Morales LM, Molero-Conejo E, Casanova A, Campos G, Raleigh X, et al. Niveles de Apoproteínas B, A-I y CIII como marcadores de riesgo cardiovascular en adolescentes delgados y obesos. Invest Clin [Internet]. 2004 [cited 2019 Jan];45(1):29–42. Available from: https:// www.researchgate.net/publication/262665511 _Niveles_de_Apoproteinas_B_A1_y_CIII_como _Marcadores_de_riesgo_Cardiovascular_en _adolescentes_delgados_y_obesos. Spanish.

  52. Garcés C, de Oya M. Factores de riesgo cardiovascular en la edad infantil. Resultados globales del estudio Cuatro Provincias. Rev Esp Cardiol [Internet]. 2007 May [cited 2019 Feb 20]; 60(5):517–24. Available from: http://www.revespcardiol.org/es/factores-riesgocardiovascular-edad-infantil-/articulo/13106185/.Spanish.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

MEDICC Review. 2019;21